Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Genetron receives listing non-compliance notice from Nasdaq » 06:16
11/07/22
11/07
06:16
11/07/22
06:16
GTH

Genetron

/

+

Genetron has received…

Genetron has received written notification from the Nasdaq Listing staff indicating that for the last 30 consecutive business days, the closing bid price for the company's ADSs was below the minimum bid price of $1.00 per share requirement. The Nasdaq notification letter has no current effect on the listing or trading of the Company's securities on Nasdaq. The company is provided with a compliance period of 180 calendar days, or until April 26, 2023, to regain compliance. In the event the company does not regain compliance by April 26, 2023, subject to the determination by the staff of Nasdaq, the company may be eligible for an additional 180-day compliance period. The company intends to monitor the closing bid price of its ADSs between now and April 26, 2023 and will take all reasonable measures in order to regain compliance with the Nasdaq minimum bid price requirement.

ShowHide Related Items >><<
GTH Genetron
/

+

GTH Genetron
/

+

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
GTH Genetron
/

+

GTH Genetron
/

+

Over a month ago
On The Fly
Fly Intel: Pre-market Movers » 08:59
10/12/22
10/12
08:59
10/12/22
08:59
KNBE

KnowBe4

$21.58 /

-0.33 (-1.51%)

, INTC

Intel

$25.04 /

-0.155 (-0.62%)

, LOCO

El Pollo Loco

$9.08 /

-0.14 (-1.52%)

, PEP

PepsiCo

$162.58 /

+0.84 (+0.52%)

, SDPI

Superior Drilling

/

+

, GTH

Genetron

/

+

, WIT

Wipro

$4.77 /

-0.17 (-3.44%)

, PHG

Philips

$14.91 /

-0.11 (-0.73%)

, OMI

Owens & Minor

$23.18 /

+0.115 (+0.50%)

, CCJ

Cameco

$25.81 /

+0.425 (+1.67%)

, BEP

Brookfield Renewable Partners

$29.10 /

-0.115 (-0.39%)

Check out this morning's…

ShowHide Related Items >><<
WIT Wipro
$4.77 /

-0.17 (-3.44%)

SDPI Superior Drilling
/

+

PHG Philips
$14.91 /

-0.11 (-0.73%)

PEP PepsiCo
$162.58 /

+0.84 (+0.52%)

OMI Owens & Minor
$23.18 /

+0.115 (+0.50%)

LOCO El Pollo Loco
$9.08 /

-0.14 (-1.52%)

KNBE KnowBe4
$21.58 /

-0.33 (-1.51%)

INTC Intel
$25.04 /

-0.155 (-0.62%)

GTH Genetron
/

+

CCJ Cameco
$25.81 /

+0.425 (+1.67%)

BEP Brookfield Renewable Partners
$29.10 /

-0.115 (-0.39%)

KNBE KnowBe4
$21.58 /

-0.33 (-1.51%)

09/20/22 UBS
KnowBe4 price target raised to $24 from $19 at UBS
09/14/22 DA Davidson
DA Davidson starts KnowBe4 at Buy on growing market, cross-sell opportunity
09/14/22 DA Davidson
KnowBe4 initiated with a Buy at DA Davidson
08/05/22 Canaccord
KnowBe4 price target lowered to $25 from $28 at Canaccord
INTC Intel
$25.04 /

-0.155 (-0.62%)

10/12/22 Barclays
Intel price target lowered to $30 from $35 at Barclays
10/11/22 Needham
Intel price target lowered to $32 from $40 at Needham
10/11/22 Wells Fargo
Intel price target lowered to $32 from $45 at Wells Fargo
10/10/22 Northland
Intel price target lowered to $52 from $55 at Northland
LOCO El Pollo Loco
$9.08 /

-0.14 (-1.52%)

11/12/21 Benchmark
El Pollo Loco initiated with a Hold at Benchmark
PEP PepsiCo
$162.58 /

+0.84 (+0.52%)

10/10/22 Wedbush
PepsiCo initiated with an Outperform at Wedbush
10/10/22 Wedbush
PepsiCo initiated with an Outperform at Wedbush
09/30/22 JPMorgan
PepsiCo price target lowered to $186 from $188 at JPMorgan
09/27/22 Deutsche Bank
PepsiCo price target raised to $181 from $179 at Deutsche Bank
SDPI Superior Drilling
/

+

06/09/22 EF Hutton
Superior Drilling initiated with a Buy at EF Hutton
GTH Genetron
/

+

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
WIT Wipro
$4.77 /

-0.17 (-3.44%)

09/13/22 Goldman Sachs
Goldman double upgrades Wipro to Buy on attractive valuation
09/13/22 Goldman Sachs
Wipro upgraded to Buy from Sell at Goldman Sachs
07/20/22 Citi
Wipro downgraded to Sell at Citi after 'disappointing' Q1
07/20/22 Citi
Wipro downgraded to Sell from Buy at Citi
PHG Philips
$14.91 /

-0.11 (-0.73%)

10/07/22 UBS
Philips price target lowered to EUR 16.10 from EUR 16.40 at UBS
10/06/22 Deutsche Bank
Philips price target lowered to EUR 18 from EUR 22 at Deutsche Bank
09/12/22 Societe Generale
Societe Generale upgrades 'undemandingly valued' Philips to Buy
09/12/22 Societe Generale
Philips upgraded to Buy from Hold at Societe Generale
OMI Owens & Minor
$23.18 /

+0.115 (+0.50%)

08/04/22 Citi
Owens & Minor price target lowered to $52 from $58 at Citi
08/04/22 Baird
Owens & Minor price target lowered to $62 from $70 at Baird
04/26/22 Citi
Owens & Minor resumed with a Buy at Citi
03/31/22 Credit Suisse
Owens & Minor assumed with a Neutral at Credit Suisse
CCJ Cameco
$25.81 /

+0.425 (+1.67%)

08/17/22 GLJ Research
Cameco price target raised to C$48.40 from C$37.86 at GLJ Research
08/02/22 Scotiabank
Cameco price target raised to C$44 from C$43 at Scotiabank
07/07/22 Scotiabank
Cameco price target lowered to C$43 from C$47 at Scotiabank
05/06/22 Canaccord
Cameco price target lowered to C$43 from C$44 at Canaccord
BEP Brookfield Renewable Partners
$29.10 /

-0.115 (-0.39%)

09/30/22 TD Securities
TD upgrades Brookfield Renewable Partners to Action List Buy on pullback
09/30/22 TD Securities
Brookfield Renewable upgraded to Action List Buy from Buy at TD Securities
09/30/22 Mizuho
Brookfield Renewable Partners price target lowered to $33 from $38 at Mizuho
08/08/22 Desjardins
Brookfield Renewable price target raised to C$50 from C$49 at Desjardins
WIT Wipro
$4.77 /

-0.17 (-3.44%)

SDPI Superior Drilling
/

+

PHG Philips
$14.91 /

-0.11 (-0.73%)

PEP PepsiCo
$162.58 /

+0.84 (+0.52%)

OMI Owens & Minor
$23.18 /

+0.115 (+0.50%)

LOCO El Pollo Loco
$9.08 /

-0.14 (-1.52%)

KNBE KnowBe4
$21.58 /

-0.33 (-1.51%)

INTC Intel
$25.04 /

-0.155 (-0.62%)

GTH Genetron
/

+

CCJ Cameco
$25.81 /

+0.425 (+1.67%)

BEP Brookfield Renewable Partners
$29.10 /

-0.115 (-0.39%)

  • 11
    Nov
PEP PepsiCo
$162.58 /

+0.84 (+0.52%)

KNBE KnowBe4
$21.58 /

-0.33 (-1.51%)

INTC Intel
$25.04 /

-0.155 (-0.62%)

CCJ Cameco
$25.81 /

+0.425 (+1.67%)

WIT Wipro
$4.77 /

-0.17 (-3.44%)

PHG Philips
$14.91 /

-0.11 (-0.73%)

PEP PepsiCo
$162.58 /

+0.84 (+0.52%)

OMI Owens & Minor
$23.18 /

+0.115 (+0.50%)

LOCO El Pollo Loco
$9.08 /

-0.14 (-1.52%)

KNBE KnowBe4
$21.58 /

-0.33 (-1.51%)

INTC Intel
$25.04 /

-0.155 (-0.62%)

CCJ Cameco
$25.81 /

+0.425 (+1.67%)

BEP Brookfield Renewable Partners
$29.10 /

-0.115 (-0.39%)

PEP PepsiCo
$162.58 /

+0.84 (+0.52%)

INTC Intel
$25.04 /

-0.155 (-0.62%)

CCJ Cameco
$25.81 /

+0.425 (+1.67%)

Earnings
Genetron reports Q2 EPS (RMB 0.49) vs. (RMB 0.17) last year » 06:15
10/12/22
10/12
06:15
10/12/22
06:15
GTH

Genetron

/

+

Reports Q2 revenue RMB…

Reports Q2 revenue RMB 137.7M vs. RMB 140.5M last year. Cash and cash equivalents and current financial assets at fair value through profit or loss were RMB 472.7M as of June 30, 2022.

ShowHide Related Items >><<
GTH Genetron
/

+

GTH Genetron
/

+

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
GTH Genetron
/

+

Over a quarter ago
Hot Stocks
Genetron special committee retains Kroll, Davis Polk & Wardwell » 07:02
09/02/22
09/02
07:02
09/02/22
07:02
GTH

Genetron

$1.13 /

-0.03 (-2.59%)

Genetron Holdings…

Genetron Holdings announced that the special committee of the Company's Board of Directors has retained Kroll as its independent financial advisor and Davis Polk & Wardwell as its independent legal counsel. The Special Committee was formed to evaluate and consider the previously announced preliminary non-binding acquisition proposal letter dated August 21, 2022 as well as other potential strategic alternatives that the Company may pursue.

ShowHide Related Items >><<
GTH Genetron
$1.13 /

-0.03 (-2.59%)

GTH Genetron
$1.13 /

-0.03 (-2.59%)

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$1.13 /

-0.03 (-2.59%)

Hot Stocks
Genetron confirms preliminary non-binding acquisition proposal from CEO » 06:03
08/22/22
08/22
06:03
08/22/22
06:03
GTH

Genetron

$1.19 /

-0.06 (-4.80%)

Genetron announced that…

Genetron announced that its Board of Directors has received a preliminary non-binding proposal letter, dated August 21, from Mr. Sizhen Wang, co-founder, chairman of the Board and CEO of the company to acquire all of the outstanding ordinary shares, par value $0.00002 per share of the company, including the Ordinary Shares represented by the American depositary shares of the company for 27.2c per Ordinary Share or $1.36 per ADS in cash. According to the Proposal Letter, the Proposing Buyer intends to fund the consideration payable in the Proposed Transaction with a combination of debt and equity capital. Equity financing is expected to be provided in the form of rollover equity in the Company and cash contributions from the Proposing Buyer and third party sponsors. The Board has formed a special committee consisting of two independent directors, Wing Kee Lau and Dian Kang, to evaluate and consider the Proposed Transaction as well as other potential strategic alternatives that the company may pursue. The Special Committee intends to retain advisors, including an independent financial advisor and independent legal counsel, to assist it in its evaluation. The Board cautions the company's shareholders and others considering trading the company's securities that the Board has just received the Proposal Letter and has not had an opportunity to carefully review or evaluate the proposal, or make any decision with respect to the company's response to the Proposed Transaction or any alternative strategic option that the company may pursue. There can be no assurance that any definitive offer will be received, that any definitive agreement will be executed relating to the Proposed Transaction or that this or any other transaction will be approved or consummated. The company does not undertake any obligation to provide any updates with respect to this or any other transaction, except as required under applicable law.

ShowHide Related Items >><<
GTH Genetron
$1.19 /

-0.06 (-4.80%)

GTH Genetron
$1.19 /

-0.06 (-4.80%)

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$1.19 /

-0.06 (-4.80%)

Earnings
Genetron reaffirms 2022 revenue view RMB 585M - RMB 638M » 07:28
06/02/22
06/02
07:28
06/02/22
07:28
GTH

Genetron

$1.47 /

+0.03 (+2.08%)

Genetron Health…

Genetron Health reiterates its full year 2022 revenue to be around RMB 585-638 million, representing 10-20% growth over its revenue in 2021.

ShowHide Related Items >><<
GTH Genetron
$1.47 /

+0.03 (+2.08%)

GTH Genetron
$1.47 /

+0.03 (+2.08%)

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$1.47 /

+0.03 (+2.08%)

Earnings
Genetron reports Q1 adjusted EPS (RMB 0.35) vs. (RMB 0.23) last year » 07:27
06/02/22
06/02
07:27
06/02/22
07:27
GTH

Genetron

$1.47 /

+0.03 (+2.08%)

Reports Q1 revenue RMB…

Reports Q1 revenue RMB 110.3M vs. RMB 92.1M last year. "While the "zero COVID" strategy in China and the lockdowns in our key markets have led to restricting operations and limiting patient traffic, we continue to provide important services for patients. We are pleased with the resiliency of our business and our ability to grow each of our segments in the first quarter," said Mr. Sizhen Wang, co-founder, Chairman and CEO of Genetron Health. "Data publications in Clinical and Translational Medicine and our presentations at the AACR Annual Meeting 2022 continue to demonstrate the capabilities of our innovative technology and this will support product adoption and advance our product pipeline. Against the backdrop of a challenging operating environment, we are committed to forging ahead with our major pipeline assets that would be key drivers for our future growth. At the same time, management is mindful of improving the Company's operational excellence. Overall, we are confident about our long-term competitive position and expect our solutions to become more widely adopted as government policy prioritizes optimal healthcare for citizens."

ShowHide Related Items >><<
GTH Genetron
$1.47 /

+0.03 (+2.08%)

GTH Genetron
$1.47 /

+0.03 (+2.08%)

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$1.47 /

+0.03 (+2.08%)

Hot Stocks
Genetron receives CE Mark for FusionScan Plus Kit » 06:10
06/01/22
06/01
06:10
06/01/22
06:10
GTH

Genetron

$1.44 /

+0.01 (+0.70%)

Genetron announced it has…

Genetron announced it has obtained a CE Mark for its FusionScan Plus Kit, an integrated DNA and RNA NGS-based assay for simultaneously detecting multiple gene mutations and fusions with lower thresholds. Receipt of the CE Mark is an important step for the acceleration of FusionScan Plus's global footprint, and its potential to enter more international clinical trials in the future.

ShowHide Related Items >><<
GTH Genetron
$1.44 /

+0.01 (+0.70%)

GTH Genetron
$1.44 /

+0.01 (+0.70%)

04/21/22 BTIG
Genetron price target lowered to $10 from $17 at BTIG
12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$1.44 /

+0.01 (+0.70%)

Recommendations
Genetron price target lowered to $10 from $17 at BTIG » 06:29
04/21/22
04/21
06:29
04/21/22
06:29
GTH

Genetron

$2.17 /

-0.04 (-1.81%)

BTIG analyst Sung Ji Nam…

BTIG analyst Sung Ji Nam lowered the firm's price target on Genetron to $10 from $17 but keeps a Buy rating on the shares. The regulatory environment for Chinese companies listed in the U.S. is showing signs of improvement, but China is potentially facing the worst wave of pandemic-related lockdowns that is currently affecting over 370M people, and the potential magnitude of the disruptions for Genetron in the near-term is uncertain, the analyst tells investors in a research note.

ShowHide Related Items >><<
GTH Genetron
$2.17 /

-0.04 (-1.81%)

GTH Genetron
$2.17 /

-0.04 (-1.81%)

12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$2.17 /

-0.04 (-1.81%)

Hot Stocks
Genetron receives CE Mark for Seq-MRD » 06:06
04/19/22
04/19
06:06
04/19/22
06:06
GTH

Genetron

$2.11 /

-0.09 (-4.09%)

Genetron announced it has…

Genetron announced it has received a CE Mark for its proprietary Human B Lymphocyte Minimal Residual Disease Detection Kit, which is also known as Seq-MRD. Based on high-throughput next generation sequencing technology, Seq-MRD assay is intended to test the CDR3 regional sequence of the IgH/K/L gene of the B cell receptor in bone marrow samples collected from patients with B lymphpocytic leukemia and multiple myeloma before and after the treatment. By screening out significant and specific clonal rearrangement form in a patient's tumor cells, this approach can detect minimal residual disease and provide a reference for the follow-up treatment of cancer survivors.

ShowHide Related Items >><<
GTH Genetron
$2.11 /

-0.09 (-4.09%)

GTH Genetron
$2.11 /

-0.09 (-4.09%)

12/16/21 BTIG
Genetron price target lowered to $17 from $21 at BTIG
09/27/21 BTIG
Genetron price target lowered to $21 from $25 at BTIG
GTH Genetron
$2.11 /

-0.09 (-4.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.